About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« ToolGen Files Opposition to CVC Substantive Preliminary Motion No. 1 for Priority Benefit | Main | MyMail, Ltd. v. ooVoo, LLC (Fed. Cir. 2021) »

August 18, 2021


One cannot, of course, raise written description issues in an IPR, but Lilly needs never worry about *any* of those claims. Even the ones that survived the IPRs would fail on §112(a) grounds if ever they were asserted in court.

BTW, did anyone else have a dickens of a time while reading these cases in remembering that Teva was the *patentee* here and Lilly the IPR petitioner? That is not the usual arrangement when you see those two names across the “v.” in a published opinion.

I will confess, Greg, that I had to check that I had the parties right a few times.

Interestingly, in district court litigation related to these IPRs Teva has asked the Court for discovery sanctions. So we should see if Sec. 112(a) becomes the/a basis for Lilly to prevail (unless it settles, of course).

Thanks for the comment.

The comments to this entry are closed.

July 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31